payment from unappropriated retained earnings of THB 0.0313 per share to shareholders whose name appear on the record date on 8 May 2018. The payment date is on 25 May 2018. Management outlook and future
Company’s paid-up share. Moreover, Mr. Weerachart Lohsiri holds 1.39 percent of the Company’s paid-up share and Mr. Weerachart Lohsiri ‘s wife Mrs. Thicomporn Chai-Iam holds 1.16 percent of the Company’s paid
million and earnings per share of Baht 0.54, an increase of 22% when compared to consolidated profits (attributable to equity holders of the parent) of Baht 887 million and earnings per share of Baht 0.45
Baht) % Revenue from Sales 179.87 167.42 168.99 167.41 1.58 0.94 Other Revenue 2.75 3.04 2.33 3.04 (0.71) (23.36) Total Revenue 182.62 170.46 171.32 170.45 0.87 0.51 Costs of Sales 130.45 121.41 126.04
the parent) of Baht 310 million and earnings per share of Baht 0.16 for the first quarter of 2019, an increase of 20 percent when compared to the consolidated profits (attributable to equity holders of
(Million Baht) % Revenue from Sales 50.24 40.30 45.53 39.82 5.71 14.34 Other Revenue 0.57 0.35 0.44 0.36 0.08 22.64 Total Revenue 50.81 40.65 45.97 40.18 5.79 14.43 Costs of Sales 36.67 30.77 35.05 30.53
Total Revenue 43.82 42.82 1.00 2.34 43.69 42.43 1.25 2.95 Costs of Sales (34.07) (30.47) (3.59) 11.78 (33.99) (29.90) (4.09) 13.67 Selling Expenses (3.16) (2.86) (0.31) 10.84 (3.16) (2.85) (0.31) 10.84
selling medical equipment 108.10 63.62 Administrative expenses 99.81 104.41 Finance costs 23.47 23.13 Finance costs (net) 21.16 20.58 Proportion of cost of medical treatment / revenue of medical treatment
service business in Q3/2017 was THB 0.51 million increased in positive trend by 99% compared to the same period in the previous year because some costs have been reclassified to selling and administrative
398.21 314.81 Administrative expenses 460.64 414.05 Loss from Impairment of Investment 56.89 - Finance costs 61.87 92.81 Finance costs (net) 46.22 83.33 Proportion of cost of medical treatment / revenue of